CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Dyne Therapeutics shares slide after pricing $375 million public offering (NASDAQ:DYN)

Negative
AI Analysis

Summary

Dyne Therapeutics completed a $375 million public offering, with shares declining following the pricing announcement.

Importance:5/10
Sentiment:
-0.30
public offeringequity offeringstock decline
Related Companies

Read the original article

Published by yahoo_finance on July 22, 2026 12:29 PM

Read Original